Clinical Development-Rheumatoid Arthritis-Israeli Company-Positive Data-Psoriasis

Israel's Can-Fite sees positive data for psoriasis drug

TEL AVIV (Reuters) - Can-Fite BioPharma expects to publish positive data at the end of the third quarter regarding the safety and efficacy of its CF101 drug under development for the treatment of Psoriasis, the Israeli company's acting CEO said on Wednesday. CF101, a small molecule oral drug, is in advanced clinical development for the treatment of autoimmune inflammatory diseases such as psoriasis, which affects the skin, and rheumatoid arthritis. ... read more..

source:http://yhoo.it/Qv2BzX

Type 2 Diabetes-Healthday News-Psoriasis-Odds

Could Psoriasis Increase Odds for Type 2 Diabetes?

MONDAY, June 18 (Healthday News) -- People suffering from the autoimmune skin disorder known as psoriasis may face an increased risk of developing Type 2 diabetes, a new study suggests. read more..

source:http://yhoo.it/Mao0un

Experimental Drugs-Healthday News-Skin Cancer-Psoriasis

Two Experimental Drugs Could Improve Psoriasis Treatment

WEDNESDAY, March 28 (Healthday News) -- A new type of treatment may be on the horizon for people with moderate to severe cases of the chronic skin condition known as Psoriasis. read more..

source:http://yhoo.it/H0btJm

Study Reveals Trigger That May Speed Melanoma Growth

WEDNESDAY, March 28 (Healthday News) -- Growth of the deadly Skin Cancer melanoma may be triggered by the immune system turning on itself, according to a new study that also identified the mechanism that causes this to happen. read more..

source:http://yhoo.it/H0buwY

Skin Condition Psoriasis-Healthday News-Immune System-Smoking

Smoking Linked to Higher Rate of Psoriasis: Study

FRIDAY, March 2 (Healthday News) -- Smokers are at higher risk of developing the autoimmune skin condition psoriasis than nonsmokers, a new study finds, possibly because smoking pushes the body's Immune System into overdrive, one expert suggests. read more..

source:http://yhoo.it/xObXN3